BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 20551467)

  • 1. Amiloride reduces portal hypertension in rat liver cirrhosis.
    Steib CJ; Hennenberg M; Beitinger F; Hartmann AC; Bystron M; De Toni EN; Gerbes AL
    Gut; 2010 Jun; 59(6):827-36. PubMed ID: 20551467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kupffer cell activation by hydrogen peroxide: a new mechanism of portal pressure increase.
    Steib CJ; Bilzer M; Härtl JM; Beitinger F; Gülberg V; Göke B; Gerbes AL
    Shock; 2010 Apr; 33(4):412-8. PubMed ID: 20118678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with the leukotriene inhibitor montelukast for 10 days attenuates portal hypertension in rat liver cirrhosis.
    Steib CJ; Bilzer M; op den Winkel M; Pfeiler S; Hartmann AC; Hennenberg M; Göke B; Gerbes AL
    Hepatology; 2010 Jun; 51(6):2086-96. PubMed ID: 20512996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrahepatic upregulation of RhoA and Rho-kinase signalling contributes to increased hepatic vascular resistance in rats with secondary biliary cirrhosis.
    Zhou Q; Hennenberg M; Trebicka J; Jochem K; Leifeld L; Biecker E; Sauerbruch T; Heller J
    Gut; 2006 Sep; 55(9):1296-305. PubMed ID: 16492715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitroflurbiprofen, a nitric oxide-releasing cyclooxygenase inhibitor, improves cirrhotic portal hypertension in rats.
    Laleman W; Van Landeghem L; Van der Elst I; Zeegers M; Fevery J; Nevens F
    Gastroenterology; 2007 Feb; 132(2):709-19. PubMed ID: 17258737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kupffer cell activation in normal and fibrotic livers increases portal pressure via thromboxane A(2).
    Steib CJ; Gerbes AL; Bystron M; Op den Winkel M; Härtl J; Roggel F; Prüfer T; Göke B; Bilzer M
    J Hepatol; 2007 Aug; 47(2):228-38. PubMed ID: 17573142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of thromboxane A2 in early BDL-induced portal hypertension.
    Yokoyama Y; Xu H; Kresge N; Keller S; Sarmadi AH; Baveja R; Clemens MG; Zhang JX
    Am J Physiol Gastrointest Liver Physiol; 2003 Mar; 284(3):G453-60. PubMed ID: 12431905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HSC-specific inhibition of Rho-kinase reduces portal pressure in cirrhotic rats without major systemic effects.
    Klein S; Van Beuge MM; Granzow M; Beljaars L; Schierwagen R; Kilic S; Heidari I; Huss S; Sauerbruch T; Poelstra K; Trebicka J
    J Hepatol; 2012 Dec; 57(6):1220-7. PubMed ID: 22878469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amelioration of portal hypertension and the hyperdynamic circulatory syndrome in cirrhotic rats by neuropeptide Y via pronounced splanchnic vasoaction.
    Moleda L; Trebicka J; Dietrich P; Gäbele E; Hellerbrand C; Straub RH; Sauerbruch T; Schoelmerich J; Wiest R
    Gut; 2011 Aug; 60(8):1122-32. PubMed ID: 21317421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Terutroban, a TP-receptor antagonist, reduces portal pressure in cirrhotic rats.
    Rosado E; Rodríguez-Vilarrupla A; Gracia-Sancho J; Tripathi D; García-Calderó H; Bosch J; García-Pagán JC
    Hepatology; 2013 Oct; 58(4):1424-35. PubMed ID: 23703868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoA/Rho-kinase and activation of endothelial nitric oxide synthase.
    Trebicka J; Hennenberg M; Laleman W; Shelest N; Biecker E; Schepke M; Nevens F; Sauerbruch T; Heller J
    Hepatology; 2007 Jul; 46(1):242-53. PubMed ID: 17596891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nebivolol treatment increases splanchnic blood flow and portal pressure in cirrhotic rats via modulation of nitric oxide signalling.
    Reiberger T; Payer BA; Schwabl P; Hayden H; Horvatits T; Jäger B; Hummel T; Mitterhauser M; Trauner M; Fuhrmann V; Angermayr B; Peck-Radosavljevic M;
    Liver Int; 2013 Apr; 33(4):561-8. PubMed ID: 23331709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Administration of a low dose of sildenafil for 1 week decreases intrahepatic resistance in rats with biliary cirrhosis: the role of NO bioavailability.
    Lee KC; Yang YY; Huang YT; Lee FY; Hou MC; Lin HC; Lee SD
    Clin Sci (Lond); 2010 Apr; 119(1):45-55. PubMed ID: 20132096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resveratrol improves intrahepatic endothelial dysfunction and reduces hepatic fibrosis and portal pressure in cirrhotic rats.
    Di Pascoli M; Diví M; Rodríguez-Vilarrupla A; Rosado E; Gracia-Sancho J; Vilaseca M; Bosch J; García-Pagán JC
    J Hepatol; 2013 May; 58(5):904-10. PubMed ID: 23262250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic administration of ursodeoxycholic acid decreases portal pressure in rats with biliary cirrhosis.
    Yang YY; Huang YT; Lee KC; Lee FY; Lee TY; Hou MC; Lin HC; Lee SD
    Clin Sci (Lond); 2009 Jan; 116(1):71-9. PubMed ID: 18479249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superoxide dismutase gene transfer reduces portal pressure in CCl4 cirrhotic rats with portal hypertension.
    Laviña B; Gracia-Sancho J; Rodríguez-Vilarrupla A; Chu Y; Heistad DD; Bosch J; García-Pagán JC
    Gut; 2009 Jan; 58(1):118-25. PubMed ID: 18829979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional relevance of the cannabinoid receptor 2 - heme oxygenase pathway: a novel target for the attenuation of portal hypertension.
    Steib CJ; Gmelin L; Pfeiler S; Schewe J; Brand S; Göke B; Gerbes AL
    Life Sci; 2013 Oct; 93(16):543-51. PubMed ID: 24007798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defective RhoA/Rho-kinase signaling contributes to vascular hypocontractility and vasodilation in cirrhotic rats.
    Hennenberg M; Biecker E; Trebicka J; Jochem K; Zhou Q; Schmidt M; Jakobs KH; Sauerbruch T; Heller J
    Gastroenterology; 2006 Mar; 130(3):838-54. PubMed ID: 16530523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelin induced contractility of stellate cells from normal and cirrhotic rat liver: implications for regulation of portal pressure and resistance.
    Rockey DC; Weisiger RA
    Hepatology; 1996 Jul; 24(1):233-40. PubMed ID: 8707268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LPS exacerbates endothelin-1 induced activation of cytosolic phospholipase A2 and thromboxane A2 production from Kupffer cells of the prefibrotic rat liver.
    Miller AM; Masrorpour M; Klaus C; Zhang JX
    J Hepatol; 2007 Feb; 46(2):276-85. PubMed ID: 17161492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.